Phathom Pharmaceuticals OverviewPhathom Pharmaceuticals Operating Income
Operating Income for PHAT.
Quarterly Operating Income
$-15477000.00
↓ 80.37% YoY
As of Mar 31, 2026
Annual Operating Income (TTM)
$-96600000.00
↓ 66.27% YoY
Trailing 12 months ending Mar 31, 2026